These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10856453

  • 1. Enalapril and valsartan improve cyclosporine A-induced vascular dysfunction in spontaneously hypertensive rats.
    Lassila M, Finckenberg P, Pere AK, Vapaatalo H, Nurminen ML.
    Eur J Pharmacol; 2000 Jun 09; 398(1):99-106. PubMed ID: 10856453
    [Abstract] [Full Text] [Related]

  • 2. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, Nurminen ML.
    Br J Pharmacol; 2000 Jul 09; 130(6):1339-47. PubMed ID: 10903974
    [Abstract] [Full Text] [Related]

  • 3. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
    Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H, Muller D, Park JK, Luft FC, Mervaala EM.
    Hypertension; 2001 Feb 09; 37(2 Pt 2):433-9. PubMed ID: 11230314
    [Abstract] [Full Text] [Related]

  • 4. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D, Porteri E, Bettoni G, Piccoli A, Castellano M, Muiesan ML, Pasini G, Guelfi D, Rosei EA.
    J Cardiovasc Pharmacol; 1998 Nov 09; 32(5):798-806. PubMed ID: 9821855
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
    Kometani M, Hayashi N, Yamamoto S, Nakao K, Inukai T.
    Arzneimittelforschung; 1997 May 09; 47(5):613-9. PubMed ID: 9205774
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats.
    Seki T, Goto K, Kansui Y, Ohtsubo T, Matsumura K, Kitazono T.
    J Am Heart Assoc; 2017 Oct 17; 6(10):. PubMed ID: 29042424
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
    de Gasparo M, Hess P, Nuesslein-Hildesheim B, Bruneval P, Clozel JP.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun 17; 1(2):151-8. PubMed ID: 11967807
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
    Kalliovalkama J, Kähönen M, Tolvanen JP, Wu X, Voipio J, Pekki A, Doris PA, Ylitalo P, Pörsti I.
    Pharmacol Toxicol; 2000 Jan 17; 86(1):36-43. PubMed ID: 10720105
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S, Jin D, Kimura M, Kirimura K, Sakonjo H, Tanaka K, Miyazaki M.
    Hypertens Res; 2007 Dec 17; 30(12):1231-7. PubMed ID: 18344629
    [Abstract] [Full Text] [Related]

  • 16. Effects of ACE inhibition on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on a high-sodium diet.
    Mervaala E, Lassila M, Vaskonen T, Krogerus L, Lähteenmäki T, Vapaatalo H, Karppanen H.
    Blood Press; 1999 Dec 17; 8(1):49-56. PubMed ID: 10412883
    [Abstract] [Full Text] [Related]

  • 17. Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipine.
    Ledingham JM, Phelan EL, Cross MA, Laverty R.
    J Vasc Res; 2000 Dec 17; 37(2):134-45. PubMed ID: 10754398
    [Abstract] [Full Text] [Related]

  • 18. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL, Cao Z, Rumble JR, Cooper ME, Johnston CI.
    Am J Hypertens; 1996 Sep 17; 9(9):895-901. PubMed ID: 8879346
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive treatment improves endothelium-dependent hyperpolarization in the mesenteric artery of spontaneously hypertensive rats.
    Onaka U, Fujii K, Abe I, Fujishima M.
    Circulation; 1998 Jul 14; 98(2):175-82. PubMed ID: 9679724
    [Abstract] [Full Text] [Related]

  • 20. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
    Nunes VW, Fortes ZB, Nigro D, Carvalho MH, Zorn TM, Scivoletto R.
    Gen Pharmacol; 2000 Feb 14; 34(2):117-25. PubMed ID: 10974419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.